浙江巨化股份有限公司董事会九届二十三次(通讯方式)会议决议公告

Core Viewpoint - Zhejiang Juhua Co., Ltd. has announced a significant asset impairment provision of 320.89 million yuan for its subsidiary, reflecting challenges in its production facilities and market conditions, while also projecting a substantial increase in net profit for 2025 [2][6][9]. Group 1: Asset Impairment Provision - The company has decided to recognize an asset impairment provision totaling 320.89 million yuan for its production facilities, including cyclohexanone, caprolactam, and dibutyl oxime production units [2][6]. - The impairment provision includes 99.55 million yuan for the cyclohexanone unit, 206.71 million yuan for the caprolactam unit, and 14.63 million yuan for the dibutyl oxime unit [6]. - The decision to recognize the impairment is based on the outdated technology of the cyclohexanone unit, ongoing losses in the caprolactam unit due to market conditions, and the cessation of operations for the dibutyl oxime unit since September 2025 [4][5][6]. Group 2: Financial Performance Forecast - The company expects its net profit attributable to shareholders for 2025 to be between 3.54 billion yuan and 3.94 billion yuan, representing an increase of 1.58 billion yuan to 1.98 billion yuan compared to the previous year, which translates to a growth rate of 80% to 101% [9][11]. - The projected net profit, excluding non-recurring gains and losses, is estimated to be between 3.514 billion yuan and 3.914 billion yuan, indicating an increase of 1.611 billion yuan to 2.011 billion yuan, with a growth rate of 85% to 106% [11][15]. - The primary drivers for this significant profit increase are the recovery in prices of core products, particularly fluorinated refrigerants, and stable production and sales volumes [15][16]. Group 3: Operational Adjustments - The company has implemented measures to optimize its asset structure and focus on its core business in fluorinated and chlorinated new materials, which aligns with its long-term interests [6][16]. - The company has actively managed production and market challenges, ensuring stable production and sales to enhance quality and efficiency [16]. - The asset impairment provision is part of the company's strategy to reflect its asset status accurately and improve financial reporting [6][7].